Hunan Fangsheng Pharmaceutical Co., Ltd.
SSE:603998.SS
10.79 (CNY) • At close June 11, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets: | ||||||||||||||
| Current Assets: | ||||||||||||||
| Cash & Cash Equivalents
| 308.46 | 208.977 | 399.724 | 258.885 | 318.849 | 156.124 | 318.203 | 140.663 | 363.428 | 532.594 | 497.212 | 126.65 | 49.719 | 80.218 |
| Short Term Investments
| 239.099 | 20.326 | 40.31 | 15.416 | 0.296 | 0.287 | -56.509 | -54.238 | -3.656 | 0 | 0 | 0 | 0 | 0 |
| Cash and Short Term Investments
| 308.46 | 229.304 | 440.034 | 274.301 | 319.145 | 156.411 | 318.203 | 140.663 | 363.428 | 532.594 | 497.212 | 126.65 | 49.719 | 80.218 |
| Net Receivables
| 323.192 | 256.762 | 191.952 | 306.413 | 205.364 | 176.056 | 115.917 | 69 | 50.226 | 36.155 | 30.87 | 27.732 | 0 | 0 |
| Inventory
| 376.152 | 328.284 | 303.398 | 256.725 | 209.777 | 206.513 | 192.673 | 172.402 | 104.7 | 85.857 | 86.569 | 76.66 | 74.85 | 39.693 |
| Other Current Assets
| 129.736 | 106.32 | 255.705 | 335.605 | 61.406 | 75.963 | 72.586 | 162.345 | 33.587 | 43.381 | 6.578 | 5.463 | 37.221 | 31.418 |
| Total Current Assets
| 1,137.539 | 920.669 | 1,191.088 | 866.631 | 795.693 | 644.942 | 699.406 | 513.097 | 551.961 | 697.988 | 621.228 | 236.505 | 179.725 | 172.571 |
| Non-Current Assets: | ||||||||||||||
| Property, Plant & Equipment, Net
| 1,109.563 | 1,051.308 | 841.253 | 823.029 | 657.054 | 601.41 | 451.534 | 422.056 | 361.51 | 244.107 | 195.716 | 136.055 | 126.756 | 93.208 |
| Goodwill
| 269.025 | 274.405 | 246.438 | 378.731 | 250.903 | 252.133 | 109.162 | 96.909 | 96.909 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 281.591 | 267.678 | 273.708 | 249.951 | 227.037 | 242.546 | 159.552 | 154.614 | 131.692 | 111.253 | 84.829 | 87.676 | 59.287 | 61.523 |
| Goodwill and Intangible Assets
| 550.616 | 542.083 | 520.146 | 628.682 | 477.94 | 494.679 | 268.714 | 251.523 | 228.601 | 111.253 | 84.829 | 87.676 | 59.287 | 61.523 |
| Long Term Investments
| 0 | 237.197 | 212.658 | 178.497 | 139.501 | 120.643 | 197.572 | 179.1 | 118.518 | 2.519 | 0 | 0 | 0 | 0 |
| Tax Assets
| 10.147 | 15.605 | 3.993 | 1.529 | 1.362 | 1.104 | 1.023 | 0.454 | 0.413 | 0.108 | 0.093 | 0.108 | 0.046 | 0.079 |
| Other Non-Current Assets
| 458.708 | 314.123 | 153.012 | 206.106 | 171.231 | 132.163 | 24.409 | 6.713 | 9.999 | 10.7 | 26.56 | 6 | 10 | 0 |
| Total Non-Current Assets
| 2,129.034 | 2,160.316 | 1,731.062 | 1,837.843 | 1,447.088 | 1,349.998 | 943.253 | 859.846 | 719.042 | 368.688 | 307.198 | 229.839 | 196.089 | 154.811 |
| Total Assets
| 3,266.573 | 3,080.986 | 2,922.15 | 2,704.475 | 2,242.781 | 1,994.941 | 1,642.659 | 1,372.943 | 1,271.003 | 1,066.675 | 928.426 | 466.344 | 375.814 | 327.382 |
| Liabilities & Equity: | ||||||||||||||
| Current Liabilities: | ||||||||||||||
| Account Payables
| 244.262 | 245.816 | 165.608 | 117.18 | 103.505 | 94.87 | 48.311 | 43.835 | 30.067 | 45.214 | 13.246 | 29.437 | 18.455 | 28.325 |
| Short Term Debt
| 531.486 | 309.194 | 210.249 | 995.392 | 413.742 | 275.69 | 180.244 | 66.289 | 65.2 | 0 | 0 | 0 | 0 | 0 |
| Tax Payables
| 19.333 | 20.852 | 47.364 | 26.979 | 43.128 | 9.184 | 13.282 | 4.34 | 13.26 | 8.707 | 5.084 | 4.595 | 1.048 | 5.801 |
| Deferred Revenue
| 0 | 0 | 87.465 | 665.983 | 355.665 | 294.058 | 13.282 | 146.879 | 122.015 | -20 | 0 | 0 | 0 | 0 |
| Other Current Liabilities
| 503.448 | 672.226 | 576.367 | 608.347 | -30.063 | 15.341 | 214.692 | 167.778 | 127.458 | 40.488 | 35.847 | 22.214 | 18.288 | 18.514 |
| Total Current Liabilities
| 1,298.529 | 1,248.089 | 999.587 | 1,255.457 | 876.541 | 689.143 | 469.811 | 282.241 | 235.985 | 94.41 | 54.177 | 56.247 | 37.791 | 52.641 |
| Non-Current Liabilities: | ||||||||||||||
| Long Term Debt
| 165.545 | 174.005 | 298.699 | 64.791 | 72.755 | 30.285 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue Non-Current
| 34.056 | 32.86 | 37.225 | 53.409 | 57.947 | 56.511 | 56.42 | 49.164 | 50.865 | 40.533 | 32.308 | 0 | 0 | 0 |
| Deferred Tax Liabilities Non-Current
| 33.574 | 34.509 | 33.655 | 27.174 | 17.303 | 16.568 | 3.583 | 3.981 | 4.459 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities
| 0 | 2.796 | 7.81 | 0 | 47.496 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 19.192 | 16.246 |
| Total Non-Current Liabilities
| 233.176 | 244.17 | 414.614 | 145.374 | 100.509 | 103.363 | 60.003 | 53.145 | 55.323 | 40.533 | 32.308 | 23.25 | 19.192 | 16.246 |
| Total Liabilities
| 1,531.705 | 1,492.26 | 1,414.201 | 1,400.831 | 977.05 | 792.506 | 529.815 | 335.386 | 291.308 | 134.942 | 86.485 | 79.496 | 56.982 | 68.887 |
| Equity: | ||||||||||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 12.673 | 0 | 0 | 0 | 0 | 0 |
| Common Stock
| 439.085 | 439.734 | 439.306 | 429.43 | 429.43 | 434.457 | 428.563 | 430.936 | 433.007 | 141.732 | 109.025 | 81.765 | 81.765 | 81.765 |
| Retained Earnings
| 837.408 | 715.882 | 704.651 | 546.159 | 512.471 | 508.494 | 451.615 | 389.833 | 340.54 | 306.075 | 270.146 | 196.876 | 138.217 | 86.148 |
| Accumulated Other Comprehensive Income/Loss
| 0 | 0 | 94.487 | 88.524 | 77.912 | 51.196 | 36.729 | 10.516 | -12.673 | 40.524 | 0 | 0 | 0 | 0 |
| Other Total Stockholders Equity
| 346.473 | 302.478 | 134.241 | 131.932 | 131.932 | 183.957 | 173.813 | 163.884 | 142.224 | 397.106 | 428.673 | 78.524 | 73.771 | 67.216 |
| Total Shareholders Equity
| 1,622.965 | 1,458.094 | 1,390.129 | 1,196.045 | 1,151.744 | 1,126.908 | 1,053.991 | 984.653 | 928.443 | 885.437 | 807.844 | 357.166 | 293.753 | 235.129 |
| Total Equity
| 1,734.868 | 1,588.726 | 1,507.949 | 1,303.644 | 1,265.731 | 1,202.434 | 1,112.844 | 1,037.558 | 979.694 | 931.733 | 841.941 | 386.848 | 318.832 | 258.495 |
| Total Liabilities & Shareholders Equity
| 3,266.573 | 3,080.986 | 2,922.15 | 2,704.475 | 2,242.781 | 1,994.941 | 1,642.659 | 1,372.943 | 1,271.003 | 1,066.675 | 928.426 | 466.344 | 375.814 | 327.382 |